@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_head { this: np:hasAssertion dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_assertion; np:hasProvenance dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_provenance; np:hasPublicationInfo dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_publicationInfo; a np:Nanopublication . dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_assertion a np:Assertion . dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_provenance a np:Provenance . dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_publicationInfo a np:PublicationInfo . } dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_assertion { miriam-gene:367 a ncit:C16612 . lld:C0376358 a ncit:C7057 . dgn-gda:DGN909d1b597336a851ab8fbdd34e88fdd9 sio:SIO_000628 miriam-gene:367, lld:C0376358; a sio:SIO_001121 . } dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_provenance { dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_assertion dcterms:description "[Blood samples were obtained for leucocyte AR expression and hormone levels from 53 subjects, grouped into: 12 male [six young adult (27-45 years), six elderly (71-79 years)] and six female (young adult 25-45 years) healthy controls; six male-to-female transsexuals (M2F; 20-50 years) receiving stable pharmacological oral oestrogen treatment; six female-to-male transsexuals (F2M; 31-51 years) receiving stable androgen replacement therapy; five younger men (18-56 years) who had been receiving long-term androgen replacement therapy for hypogonadal disease; six elderly men (72-88 years) who had undergone medical castration for prostate cancer treatment; and 12 male bone marrow transplant recipients (BMT; 23-65 years) from either male or female donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:15638871; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP475340.RAUw5E29C_qdnSTD8xC8CD4mQ0Vhdg1bHJIvWimU5Apfg130_publicationInfo { this: dcterms:created "2016-05-13T12:45:20+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }